News Center

Home page

Peak Report

News reports

Pro 2014-030 (Announcement of Resolution of the 9th Session of the Board of Directors of Jianfeng Group)

Release time:

2020-08-05

Securities Code: 600668 Securities Abbreviation: Jianfeng Group Announcement No.: 2014-030

Bond Abbreviation: 13 Jianfeng 01 Bond Code: 122227

Zhejiang Jianfeng Group Co., Ltd.

Ninth Session of the First Board of Directors Resolution Announcement

The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and shall bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents .

On November 3, 2014, Zhejiang Jianfeng Group Co., Ltd. issued a notice to convene the first meeting of the ninth board of directors by fax, e-mail, telephone, and personal delivery. On November 12, 2014, the first meeting of the ninth board of directors of Zhejiang Jianfeng Group Co., Ltd. was held in the form of an on-site meeting. The meeting was held in the conference room on the third floor of the company. The meeting was presided over by Mr. Jiang Xiaomeng. There are nine directors in the company. Director Du Zihong entrusted director Jiang Xiaomeng to attend the meeting due to a business trip. The remaining eight directors attended the meeting in person, comply with the relevant provisions of the "Company Law" and the "Articles of Association" of the company, and the resolutions made are legal and valid. After deliberation and voting, the following resolution was passed:

1. "Proposal on Election of Chairman"

After deliberation and voting, the board of directors passed the proposal.

elected Mr. Jiang Xiaomeng as the chairman of the ninth board of directors of the company, and his term of office will expire until the expiration of the ninth board of directors.

The result of the vote was: 9 votes in favor, 0 votes against, and 0 abstentions.

2. "Proposal on Election of Special Committees of the Board of Directors"

After deliberation and voting, the board of directors passed the proposal.

elected Mr. Jiang Xiaomeng, Mr. Du Zihong, Mr. Huang Sujian, Mr. Wu Xiaoming and Mr. Shi Ximin as members of the Strategy Committee of the 9th Board of Directors, and Mr. Jiang Xiaomeng, Chairman of the Board of Directors, as Chairman of the Strategy Committee.

elected Mr. Shi Ximin, Mr. Zhang Yuyou, and Mr. Huang Sujian as members of the Audit Committee of the Ninth Board of Directors, and Mr. Shi Ximin as the chairman.

elected Mr. Zhang Yuyou, Mr. Wu Xiaoming, and Mr. Jiang Xiaomeng as members of the Nomination Committee of the Ninth Board of Directors, and Mr. Zhang Yuyou as the chairman.

elected Mr. Shi Ximin, Mr. Zhang Yuyou and Mr. Du Zihong as members of the Remuneration and Evaluation Committee of the Ninth Board of Directors, and Mr. Shi Ximin as Chairman.

Voting result: 9 votes in favor, 0 votes against and 0 abstentions.

3. "Proposal on Appointment of General Manager"

After deliberation and voting, the board of directors passed the proposal.

Mr. Yu Jianhong was appointed as the general manager of the company for a term of office until the expiration of the ninth board of directors. The resume is attached.

Voting result: 9 votes in favor, 0 votes against and 0 abstentions.

4. "Proposal on Appointment of Secretary of Board of Directors"

After deliberation and voting, the board of directors passed the proposal.

Mr. Zhu Jianwei was appointed as the secretary of the board of directors of the company until the expiration of the ninth board of directors. The resume is attached.

Voting result: 9 votes in favor, 0 votes against, 0 abstentions.

5. "Proposal on Appointment of Deputy General Manager and Chief Financial Officer"

After deliberation and voting, the board of directors passed the proposal.

appointed Mr. Huang Jinlong, Mr. Zhang Fengliang and Mr. Xiang Chongping as the deputy general manager of the company, and Mr. Lan Xiaolong as the financial director of the company. The term of office will expire until the ninth board of directors. The resume is attached.

Voting result: 9 votes in favor, 0 votes against, 0 abstentions.

6. "Proposal on Appointment of Director of Audit Office and Securities Affairs Representative"

After deliberation and voting, the board of directors passed the proposal.

appointed Mr. Xu Jianjun as the director of the company's audit office, and Mr. Zhou Hengbin as the company's securities affairs representative. The term of office will expire until the ninth board of directors. The resume is attached.

voting result: 9 votes in favor, 0 votes against and 0 abstentions.

# Three independent directors of 106 company expressed their independent opinions on the above proposal. They believed that the educational background and work experience of all the personnel appointed by the board of directors met the job requirements, and there was no situation stipulated in Article 147 of the company law and the phenomenon that the CSRC determined that the market ban or the ban had not been lifted, The nomination and appointment procedures of the above personnel are in line with the relevant provisions of the company law and the articles of association, there is no harm to the interests of small and medium shareholders.

hereby announce

Zhejiang Jianfeng Group Co., Ltd. Board of Directors

November 12, 2014

Attached: Resume

1, Mr. Yu Jianhong: Born in October 1966, Senior Economist, Joined in September 1987, Served as Deputy Director of Machine Repair Workshop and Chief of Technical Section of Jinhua Cement Factory, deputy Director and Director of Jinsong Cement Plant, General Manager of Zhejiang Jianfeng Group Jinhua Jinma Cement Co., Ltd., General Manager of Zhejiang Jianfeng Cement Co., Ltd., Deputy General Manager of the Company, currently Director and General Manager of the Company. Part-time: Vice President of Zhejiang Cement Association.

2. Mr. Zhu Jianwei: Born in November 1967, Master of Business Administration, Economist, joined the work in August 1991, and successively served as the company's planning and development department, Shanghai office, securities management department, and board of directors. Office staff, secretary of the company's board of directors.

3. Mr. Huang Jinlong: born in February 1965, master's degree, professor-level senior engineer and licensed pharmacist. Joined the work in August 1988, served as the chief and deputy director of the quality inspection section and deputy director of Zhejiang Aotokang Pharmaceutical Co., Ltd., and the manager of the development department of Zhejiang Aotokang Pharmaceutical Group; joined the company in August 1998 and served as Zhejiang Jianfeng Pharmaceutical Co., Ltd. Product Development Manager, Assistant General Manager, Deputy General Manager, Executive Deputy General Manager, General Manager, and Deputy General Manager of the Company.

4. Mr. Zhang Fengliang: born in October 1977, graduate student, master of business administration, engineer. He joined the work in August 1999 and successively served as the main operation of the kiln in the manufacturing workshop of Zhejiang Jianfeng Jinma Cement Co., Ltd., the director of the manufacturing workshop of Zhejiang Jianfeng Dengcheng Cement Co., Ltd., and the deputy general manager and executive deputy general manager of Daye Jianfeng Cement Co., Ltd. General manager, concurrently served as the vice chairman of Daye City Federation of Industry and Commerce and the vice chairman of Hubei Cement Association.

5, Mr. Xiang Chongping: 1964 June born , university undergraduate, senior economist, enterprise legal consultant, human resources manager. 19 81 1 2 April to participate in the work, served as Jinhua enterprise building co., ltd. office deputy director, vice chairman of the trade union, enterprise management manager, office director, joined the company in October 1997, served as the company's human resources deputy manager, manager. He is currently the Assistant General Manager and Human Resources Manager of the Company. He is also vice president of Jinhua Trademark Federation.

6. Mr. Lan Xiaolong: born in June 1973, bachelor's degree, accountant. He joined the work in September 1997 and served as a financial clerk of Zhejiang Jianfeng Group Co., Ltd., financial manager of Jinhua Pharmaceutical Company, deputy manager, financial manager and chief financial officer of Zhejiang Jianfeng Pharmaceutical Co., Ltd.

7. Mr. Xu Jianjun: born in March 1977, bachelor's degree, accountant. In November 1995, he worked in Zhejiang Jianfeng Communication Cable Co., Ltd., Zhejiang Jianfeng Pharmaceutical Co., Ltd., Daye Jianfeng Cement Co., Ltd., and Zhejiang Jinhua Nanfang Jianfeng Cement Co., Ltd., and is currently the deputy director of the company's audit office.

8, Mr. Zhou Hengbin, 1986 10 August, bachelor's degree. 2010

More information

The company fully deploys 2018 work

On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals

2020

07-30

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise

On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

< 1...38 39 40...61 > 跳转到页